Development of Nateglinide Loaded Graphene Oxide-Chitosan Nanocomposites: Optimization by Box Behnken Design

Author(s): Rutuja V. Deshmukh, Pavan Paraskar, S. Mishra, Jitendra Naik*.

Journal Name: Micro and Nanosystems

Volume 11 , Issue 2 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Nateglinide is an antidiabetic drug having biological half-life 1.5 h which shows a concise effect. Graphene oxide along with chitosan can be used as a nanocarrier for sustained release of Nateglinide.

Objective: To develop Nateglinide loaded graphene oxide-chitosan nanocomposites and to evaluate for different characterization studies.

Methods: Graphene Oxide (GO) was synthesized by improved hummer’s method and drug-loaded Graphene oxide - chitosan nanocomposites were prepared. Box Behnken design was used to carry out experiments. The nanocomposites were characterized for encapsulation efficiency and drug release. Morphology was studied using field emission scanning electron microscope and transmission electron microscope. An interaction between drug, polymer and GO was investigated by Fourier transform infrared spectroscopy and X-ray diffractometer along with in vitro drug release study.

Results: The statistical evaluation of the design showed linear and quadratic models which are significant models for encapsulation efficiency (R1 0.6883, 0.9473) and drug loading (R2 0.6785, 0.9336), respectively. Fourier transform infrared spectroscopy showed the compatibility of GO, Chitosan and Nateglinide. X-ray diffractometer reveals the change in degree of crystallinity of drug. FE-SEM and TEM images confirmed the distribution of the drug within the nanocomposites. Design expert reveals that the concentration of GO has great influence on encapsulation efficiency. In Vitro drug release showed the sustained release of drug over the period of 12 h.

Conclusion: GO-Chitosan nanocomposites can be used as a sustained release carrier system for Nateglinide to reduce dose frequency of drug as well as its probable side effects.

Keywords: Graphene oxide, chitosan, nateglinide, nanocomposites, drug release, box behnken design.

[1]
Seo, H.I.; Cheon, Y.A.; Chung, B.G. Graphene and thermo-responsive polymeric nanocomposites for therapeutic applications. Biomed. Eng. Lett., 2016, 6, 10-15.
[2]
Paulchamy, B.; Arthi, G.; Lignesh, B.D. A simple approach to stepwise synthesis of graphene oxide nanomaterial. J. Nanomed. Nanotechnol., 2015, 6(1), 253.
[3]
Gaikwad, G.; Patil, P.; Patil, D.; Naik, J. Synthesis and evaluation of gas sensing properties of PANI based graphene oxide nanocomposites. Mater. Sci. Eng. B, 2017, 218, 14-22.
[4]
Shareena, T.P.D.; Mc Shan, D.; Dasmahapatra, A.K.; Tchounwou, P.B. A review on graphene-based nanomaterials in biomedical applications and risks in environment and health. Nano-Micro Lett., 2018, 10(3), 53.
[5]
Rana, V.K.; Choi, M.C.; Kong, J.Y.; Ha, C.S.; Mishra, S. Synthesis and drug delivery behaviour of chitosan functionalized graphene oxide hybrid nanosheets. Macromol. Mater., 2011, 296, 131-140.
[6]
Lu, H.; Wang, J.; Wang, T.; Zhong, J.; Bao, Y.; Hao, H. Recent progress on nanostructures for drug delivery applications. J. Nanomater., 2016, 2016, 20.
[7]
Liu, J.H.; Wang, T.; Wang, H.; Gu, Y.; Xu, Y.; Tang, H.; Jia, G.; Liu, Y. Biocompatibility of graphene oxide intravenously administrated in mice-effects of dose, size and exposure protocols. Toxicol. Res., 2015, 4(1), 83-91.
[8]
Goenka, S.; Sant, V.; Sant, S. Graphene-based nanomaterial for drug delivery and tissue engineering. J. Control. Release, 2014, 173, 75-88.
[9]
Li, Y.; Liu, Y.; Fu, Y.; Wei, T.; Guyader, L.; Gao, G.; Chen, C. The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways. Biomaterials, 2012, 33, 402-411.
[10]
Waghulde, M.R.; Naik, J.B. Experimental article poly-€-caprolactone-loaded miglitol microspheres for the treatment of type- 2 diabetes mellitus using the response surface methodology. J. Taibah Univ. Med. Sci., 2014, 11, 364-373.
[11]
Waghulde, M.R.; Naik, J.B. Comparative study of encapsulated vildagliptin microparticles produced by spray drying and solvent evaporation technique. Dry. Technol., 2017, 35, 1644-1645.
[12]
Bari, S.S.; Mishra, S. Calcium silicate nanowires. An effective alternative for improving mechanical properties of chitosan-hydroxyethyl methacrylate (HEMA) copolymer nanocomposites. Carbohydr. Polym., 2017, 169, 426-432.
[13]
Bari, S.S.; Mishra, S. Effect of calcium sulphate nanorods on mechanical properties of chitosan-hydroxyethyl methacrylate (HEMA) copolymer nanocomposites. Carbohydr. Polym., 2017, 157, 409-418.
[14]
Rodrigues, S.; Dionisio, M.; Lopez, C.R.; Grenha, A. Biocompatibility of chitosan carriers with application in drug delivery. J. Funct. Biomater., 2012, 3, 615-641.
[15]
Zhang, H.; Oh, M.; Allen, C.; Kumacheva, E. Monodisperse chitosan nanoparticles for mucosal drug delivery. Biomacromolecules, 2004, 5, 2461-2468.
[16]
Yan, T.; Zhang, H.; Huang, D.; Feng, S.; Fujita, M.; Gao, X.D. Chitosan-functionalized graphene oxide as a potential immunoadjuvant. Nanomaterials (Basel), 2017, 7, 59.
[17]
Khairnar, G.; Mokale, V.; Naik, J. Formulation and development of Nateglinide loaded sustained release ethyl cellulose microspheres by O/W solvent emulsification technique. J. Pharm. Investig., 2014, 44, 411-422.
[18]
Naik, J.; Lokhande, A.; Mishra, S.; Kulkarni, R. Preparation and characterization of Nateglinide loaded hydrophobic biocompatible polymer nanoparticles. J. Inst. Eng. India Ser., 2016, 98, 269-277.
[19]
Lokhande, A.; Mishra, S.; Kulkarni, R.; Naik, J. Development and evaluation of nateglinide loaded polycaprolactone nanoparticles. Micro Nanosyst., 2015, 7, 43-48.
[20]
Lokhande, A.; Mishra, S.; Kulkarni, R.; Naik, J. Development and evaluation of nateglinide loaded polycaprolactone nanoparticles. Micro Nanosyst., 2015, 7(1), 43-48.
[21]
Kumari, A.; Singla, R.; Guliani, A.; Yadav, S.K. Review article: Nanoencapsulation for drug delivery. EXCLI J., 2014, 13, 265-286.
[22]
Deshmukh, R.K.; Naik, J.B. Diclofenac sodium-loaded Eudragit® microspheres: Optimization using statistical experimental design. J. Pharm. Innov., 2013, 8, 276-287.
[23]
Patil, P.; Khairnar, G.; Naik, J. Preparation and statistical optimization of Losartan Potassium loaded nanoparticles using Box Behnken factorial design: Microreactor precipitation. Chem. Eng. Res. Des., 2015, 104, 98-109.
[24]
Deshmukh, R.K.; Naik, J.B. Aceclofenac microspheres: Quality by design approach. Mater. Sci. Eng. C, 2014, 36, 320-328.
[25]
Jain, R.; Mishra, S. Electrical and electrochemical properties of graphene modulated through surface functionalization. RSC Advances, 2016, 6, 27404-27415.
[26]
Bari, P.; Lanjewar, S.; Hansora, D.P.; Mishra, S. Influence of the coupling agent and graphene oxide on the thermal and mechanical behaviour of tea dust–polypropylene composites. J. Appl. Polym. Sci., 2015, 133(4), 42927.
[27]
Patil, J.S.; Patil, P.B.; Sonawane, P.; Naik, J.B. Design and development of sustained release glyburide-loaded silica nanoparticles. Bull. Mater. Sci., 2017, 40, 263-270.
[28]
Yadava, S.K.; Naik, J.B.; Patil, J.S.; Mokale, V.J.; Singh, R. Enhanced solubility and bioavailability of lovastatin using stabilized form of self-emulsifying drug delivery system. Colloids Surf. A Physicochem. Eng. Asp., 2015, 481, 63-71.
[29]
Deshmukh, R.K.; Naik, J.B. Formulation of diclofenac sodium-loaded ethylcellulose microparticles using 23 factorial design approach. Micro Nanosyst., 2017, 9(1), 7-15.
[30]
Yadava, S.; Naik, J.; Patil, J.; Mokale, V. Development of encapsulated self healed microparticles: Evaluation by RSM. Micro Nanosyst., 2016, 8(1), 31-40.
[31]
Naik, J.B.; Lokhande, A.B.; Mishra, S.; Kulkarni, R.D. Effect of solvents, drug/polymer ratios, surfactant concentration on in vitro characteristics of repaglinide loaded poly (meth) acrylates nanoparticles: A comparative study. Micro Nanosyst., 2014, 6(4), 241-253.
[32]
Deshmukh, R.K.; Naik, J.B. The impact of preparation parameters on sustained release aceclofenac microspheres: A design of experiments. Adv. Powder Technol., 2015, 26(1), 244-252.
[33]
Khairnar, G.; Patil, P.; Mokale, V.; Naik, J.B. Investigation on the development of Losartan Potassium sustained release microspheres by solvent evaporation methods. Micro Nanosyst., 2015, 7(3), 190-196.
[34]
Patil, J.S.; Rajput, R.; Nemade, R.; Naik, J. Preparation and characterization of artemether loaded solid lipid nanoparticles: A 32 factorial design approach. Mater. Technol., 2018, 1-8.
[http://dx.doi.org/10.1080/ 10667857.2018.1475142]
[35]
Indian Pharmacopoeia. Indian Pharmacopoeia Commission Ghaziabad. 2007, 1, 480.
[36]
Mokale, V.J.; Khatumaria, B.; Naik, J.B.; Verma, U. Formulation and development of nanoparticles for quick and complete release of Hydrochlorothiazide by nanonization technique. Micro Nanosyst., 2014, 6, 109-117.
[37]
Deshmukh, R.; Naik, J.; Mishra, S. Preparation and characterization of glipizide loaded eudragit microparticle. Micro Nanosyst., 2018, 10(2), 129-136.
[38]
Depan, D.; Shah, J.; Misra, R.D.K. Controlled release of drug from folate-decorated and graphene mediated drug delivery system: Synthesis, loading efficiency, and drug release response. Mater. Sci. Eng. C, 2011, 31, 1305-1312.
[39]
Yang, H.; Bremner, D.H.; Tao, L.; Li, H.; Hu, J.; Zhu, L. Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery. Carbohydr. Polym., 2016, 135, 72-78.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 11
ISSUE: 2
Year: 2019
Page: [142 - 153]
Pages: 12
DOI: 10.2174/1876402911666190328221345

Article Metrics

PDF: 14
HTML: 2